187 related articles for article (PubMed ID: 21347289)
1. TRPV6 determines the effect of vitamin D3 on prostate cancer cell growth.
Lehen'kyi V; Raphaël M; Oulidi A; Flourakis M; Khalimonchyk S; Kondratskyi A; Gordienko DV; Mauroy B; Bonnal JL; Skryma R; Prevarskaya N
PLoS One; 2011 Feb; 6(2):e16856. PubMed ID: 21347289
[TBL] [Abstract][Full Text] [Related]
2. TRPV6 channel controls prostate cancer cell proliferation via Ca(2+)/NFAT-dependent pathways.
Lehen'kyi V; Flourakis M; Skryma R; Prevarskaya N
Oncogene; 2007 Nov; 26(52):7380-5. PubMed ID: 17533368
[TBL] [Abstract][Full Text] [Related]
3. RNA interference mediated suppression of TRPV6 inhibits the progression of prostate cancer
Kim DY; Kim SH; Yang EK
Investig Clin Urol; 2021 Jul; 62(4):447-454. PubMed ID: 34085788
[TBL] [Abstract][Full Text] [Related]
4. Store-operated Ca2+ current and TRPV6 channels in lymph node prostate cancer cells.
Bödding M; Fecher-Trost C; Flockerzi V
J Biol Chem; 2003 Dec; 278(51):50872-9. PubMed ID: 14534305
[TBL] [Abstract][Full Text] [Related]
5. 1α,25-Dihydroxyvitamin D
Ishizawa M; Akagi D; Yamamoto J; Makishima M
J Steroid Biochem Mol Biol; 2017 Sep; 172():55-61. PubMed ID: 28578001
[TBL] [Abstract][Full Text] [Related]
6. Temporal changes in tissue 1α,25-dihydroxyvitamin D3, vitamin D receptor target genes, and calcium and PTH levels after 1,25(OH)2D3 treatment in mice.
Chow EC; Quach HP; Vieth R; Pang KS
Am J Physiol Endocrinol Metab; 2013 May; 304(9):E977-89. PubMed ID: 23482451
[TBL] [Abstract][Full Text] [Related]
7. The human transient receptor potential vanilloid type 6 distal promoter contains multiple vitamin D receptor binding sites that mediate activation by 1,25-dihydroxyvitamin D3 in intestinal cells.
Meyer MB; Watanuki M; Kim S; Shevde NK; Pike JW
Mol Endocrinol; 2006 Jun; 20(6):1447-61. PubMed ID: 16574738
[TBL] [Abstract][Full Text] [Related]
8. TRPV6 calcium channel translocates to the plasma membrane via Orai1-mediated mechanism and controls cancer cell survival.
Raphaël M; Lehen'kyi V; Vandenberghe M; Beck B; Khalimonchyk S; Vanden Abeele F; Farsetti L; Germain E; Bokhobza A; Mihalache A; Gosset P; Romanin C; Clézardin P; Skryma R; Prevarskaya N
Proc Natl Acad Sci U S A; 2014 Sep; 111(37):E3870-9. PubMed ID: 25172921
[TBL] [Abstract][Full Text] [Related]
9. TRPV6.
Wissenbach U; Niemeyer BA
Handb Exp Pharmacol; 2007; (179):221-34. PubMed ID: 17217060
[TBL] [Abstract][Full Text] [Related]
10. Actions of vitamin D3, analogs on human prostate cancer cell lines: comparison with 1,25-dihydroxyvitamin D3.
Skowronski RJ; Peehl DM; Feldman D
Endocrinology; 1995 Jan; 136(1):20-6. PubMed ID: 7530193
[TBL] [Abstract][Full Text] [Related]
11. [Inhibitory effect of TRPV6 silencing on prostate cancer cell line LNCaP in vitro].
Zhao XZ; Guo HQ; Liu GX; Ji CW; Zhang SW; Liu TS; Gan WD; Li XG
Zhonghua Nan Ke Xue; 2010 May; 16(5):423-7. PubMed ID: 20684323
[TBL] [Abstract][Full Text] [Related]
12. Compensatory induction of the TRPV6 channel in a calbindin-D9k knockout mouse: Its regulation by 1,25-hydroxyvitamin D3.
Lee GS; Jung EM; Choi KC; Oh GT; Jeung EB
J Cell Biochem; 2009 Dec; 108(5):1175-83. PubMed ID: 19777446
[TBL] [Abstract][Full Text] [Related]
13. TRPV6 is a Ca2+ entry channel essential for Ca2+-induced differentiation of human keratinocytes.
Lehen'kyi V; Beck B; Polakowska R; Charveron M; Bordat P; Skryma R; Prevarskaya N
J Biol Chem; 2007 Aug; 282(31):22582-91. PubMed ID: 17550901
[TBL] [Abstract][Full Text] [Related]
14. TRPV6 potentiates calcium-dependent cell proliferation.
Schwarz EC; Wissenbach U; Niemeyer BA; Strauss B; Philipp SE; Flockerzi V; Hoth M
Cell Calcium; 2006 Feb; 39(2):163-73. PubMed ID: 16356545
[TBL] [Abstract][Full Text] [Related]
15. TRPV6 is not required for 1alpha,25-dihydroxyvitamin D3-induced intestinal calcium absorption in vivo.
Kutuzova GD; Sundersingh F; Vaughan J; Tadi BP; Ansay SE; Christakos S; Deluca HF
Proc Natl Acad Sci U S A; 2008 Dec; 105(50):19655-9. PubMed ID: 19073913
[TBL] [Abstract][Full Text] [Related]
16. CCAAT/enhancer-binding protein delta: a molecular target of 1,25-dihydroxyvitamin D3 in androgen-responsive prostate cancer LNCaP cells.
Ikezoe T; Gery S; Yin D; O'Kelly J; Binderup L; Lemp N; Taguchi H; Koeffler HP
Cancer Res; 2005 Jun; 65(11):4762-8. PubMed ID: 15930295
[TBL] [Abstract][Full Text] [Related]
17. Vitamin D-induced up-regulation of tumour necrosis factor alpha (TNF-alpha) in prostate cancer cells.
Golovko O; Nazarova N; Tuohimaa P
Life Sci; 2005 Jun; 77(5):562-77. PubMed ID: 15904673
[TBL] [Abstract][Full Text] [Related]
18. Calcium store contents control the expression of TRPC1, TRPC3 and TRPV6 proteins in LNCaP prostate cancer cell line.
Pigozzi D; Ducret T; Tajeddine N; Gala JL; Tombal B; Gailly P
Cell Calcium; 2006 May; 39(5):401-15. PubMed ID: 16529812
[TBL] [Abstract][Full Text] [Related]
19. Reciprocal positive regulation between TRPV6 and NUMB in PTEN-deficient prostate cancer cells.
Kim SY; Hong C; Wie J; Kim E; Kim BJ; Ha K; Cho NH; Kim IG; Jeon JH; So I
Biochem Biophys Res Commun; 2014 Apr; 447(1):192-6. PubMed ID: 24704446
[TBL] [Abstract][Full Text] [Related]
20. 1α,25-Dihydroxyvitamin D
Ben-Eltriki M; Deb S; Guns EST
J Steroid Biochem Mol Biol; 2021 May; 209():105828. PubMed ID: 33493594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
